Literature DB >> 22679252

Prevalence of calcific aortic valve disease in the elderly and associated risk factors: a population-based study in a Mediterranean area.

Ignacio Ferreira-González1, Josep Pinar-Sopena, Aida Ribera, Josep R Marsal, Purificación Cascant, Teresa González-Alujas, Arturo Evangelista, Carlos Brotons, Irene Moral, Gaietà Permanyer-Miralda, David García-Dorado, Pilar Tornos.   

Abstract

AIMS: To determine the prevalence of aortic valve sclerosis (ASC) and stenosis (AS) in the elderly in a Mediterranean area and to identify associated clinical factors. METHODS AND
RESULTS: Population cross-sectional study in a random sample of 1068 people ≥65 years in a Mediterranean area. ASC was categorized as absent, mild-to-moderate, or moderate-to-severe depending on the severity of thickening and calcification. The relation between the severity of ASC and potential risk factors was assessed by multinomial logistic regression analysis. Some degree of thickening and/or calcification was present in 45.4%, of the sample, 73.5% in >85 years. AS prevalence was 3% for the total cohort and 7.4% in >85 years. Adjusting for gender it was found that age, smoking habit, hypertension, waist circumference, and ankle-brachial index <0.9 were associated with degrees of ASC. Except for waist circumference, there was a gradient between the magnitude of association and the severity of ASC. The OR for age was 1.56 (95% CI 1.39-1.76) for mild-to-moderate ASC and 2.03 (95% CI 1.72-2.4) for moderate-to-severe ASC, and for smoking habit 1.59 (95% CI 1.08-2.34) for mild-to-moderate ASC and 2.13 (95% CI 1.19-3.78) for moderate-to-severe ASC. Diabetes and renal impairment were associated with advanced but not with early stages of ASC.
CONCLUSIONS: The prevalence of ASC and AS in people ≥65 years is similar to that reported in other regions. The gradient in the association of cardiovascular risk factors with the severity of ASC suggests that they may be causally implied in the pathogenesis of the disease.

Entities:  

Keywords:  Aortic valve sclerosis; aortic valve stenosis; calcific aortic valve disease; cardiovascular risk factors

Mesh:

Year:  2012        PMID: 22679252     DOI: 10.1177/2047487312451238

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  11 in total

1.  The impact of waiting for intervention on costs and effectiveness: the case of transcatheter aortic valve replacement.

Authors:  Aida Ribera; John Slof; Ignacio Ferreira-González; Vicente Serra; Bruno García-Del Blanco; Purificació Cascant; Rut Andrea; Carlos Falces; Enrique Gutiérrez; Raquel Del Valle-Fernández; César Morís-de laTassa; Pedro Mota; Juan Francisco Oteo; Pilar Tornos; David García-Dorado
Journal:  Eur J Health Econ       Date:  2017-11-23

2.  Bone mass density and bone metabolism marker are associated with progression of carotid and cardiac calcified plaque in Chinese elderly population.

Authors:  D Liu; L Chen; S Dong; Z Peng; H Yang; Y Chen; L Li; H Zhou; R Zhou
Journal:  Osteoporos Int       Date:  2019-06-10       Impact factor: 4.507

Review 3.  The current landscape of lipoprotein(a) in calcific aortic valvular disease.

Authors:  Grace Hsieh; Theresa Rizk; Adam N Berman; David W Biery; Ron Blankstein
Journal:  Curr Opin Cardiol       Date:  2021-09-01       Impact factor: 2.108

4.  Extra-coronary calcification (aortic valve calcification, mitral annular calcification, aortic valve ring calcification and thoracic aortic calcification) in HIV seropositive and seronegative men: Multicenter AIDS Cohort Study.

Authors:  Panteha Rezaeian; P Elliott Miller; Sabina A Haberlen; Aryabod Razipour; Hossein Bahrami; Romeo Castillo; Mallory D Witt; Lawrence Kingsley; Frank J Palella; Rine Nakanishi; Suguru Matsumoto; Anas Alani; Lisa P Jacobson; Wendy S Post; Matthew J Budoff
Journal:  J Cardiovasc Comput Tomogr       Date:  2016-02-27

5.  Traditional Cardiovascular Risk Factors and Their Relation to Future Surgery for Valvular Heart Disease or Ascending Aortic Disease: A Case-Referent Study.

Authors:  Johan Ljungberg; Bengt Johansson; Karl Gunnar Engström; Elin Albertsson; Paul Holmer; Margareta Norberg; Ingvar A Bergdahl; Stefan Söderberg
Journal:  J Am Heart Assoc       Date:  2017-05-05       Impact factor: 5.501

6.  Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China.

Authors:  Yong-Tao Wang; Jing Tao; Ailifeire Maimaiti; Dilare Adi; Yi-Ning Yang; Xiao-Mei Li; Xiang Ma; Fen Liu; Bang-Dang Chen; Yi-Tong Ma
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

Review 7.  The Genetic Regulation of Aortic Valve Development and Calcific Disease.

Authors:  Vinal Menon; Joy Lincoln
Journal:  Front Cardiovasc Med       Date:  2018-11-06

Review 8.  Calcific Aortic Valve Disease-Natural History and Future Therapeutic Strategies.

Authors:  Brunilda Alushi; Lavinia Curini; Mary Roxana Christopher; Herko Grubitzch; Ulf Landmesser; Amedeo Amedei; Alexander Lauten
Journal:  Front Pharmacol       Date:  2020-05-13       Impact factor: 5.810

9.  Cardiac Autonomic Response to Active Standing in Calcific Aortic Valve Stenosis.

Authors:  José M Torres-Arellano; Juan C Echeverría; Nydia Ávila-Vanzzini; Rashidi Springall; Andrea Toledo; Oscar Infante; Rafael Bojalil; Jorge E Cossío-Aranda; Erika Fajardo; Claudia Lerma
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

10.  Clinical Relevance of Plasma Endogenous Tissue-Plasminogen Activator and Aortic Valve Sclerosis: Performance as a Diagnostic Biomarker.

Authors:  Zhongli Chen; Ying Shen; Qiqi Xue; Bo Wen Lin; Xiao Yan He; Yi Bo Zhang; Ying Yang; Wei Feng Shen; Ye Hong Liu; Ke Yang
Journal:  Front Cardiovasc Med       Date:  2020-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.